These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28485352)

  • 1. An institutional analysis of clinicopathological features of triple negative breast cancer.
    Sharma D; Singh G
    Indian J Cancer; 2016; 53(4):566-568. PubMed ID: 28485352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-negative breast cancer: An institutional analysis.
    Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK
    Indian J Cancer; 2014; 51(2):163-6. PubMed ID: 25104201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological comparison of triple negative breast cancers with non-triple negative breast cancers in a hospital in North India.
    Nabi MG; Ahangar A; Wahid MA; Kuchay S
    Niger J Clin Pract; 2015; 18(3):381-6. PubMed ID: 25772923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast-conserving therapy for triple-negative breast cancer.
    Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
    JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience.
    Der EM; Gyasi RK; Tettey Y; Edusei L; Bayor MT; Jiagge E; Gyakobo M; Merajver SD; Newman LA
    Breast J; 2015; 21(6):627-33. PubMed ID: 26547900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features and prognosis of triple-negative breast cancer: a comparison between younger (<60) and elderly (≥60) patients.
    Qiu JD; Xue XY; Li R; Wang JD
    Eur J Cancer Care (Engl); 2016 Nov; 25(6):1065-1075. PubMed ID: 26122025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBC.
    Biswas T; Efird JT; Prasad S; James SE; Walker PR; Zagar TM
    Clin Breast Cancer; 2016 Jun; 16(3):212-6. PubMed ID: 26988771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic features and prognosis of triple negative breast cancer].
    Zhou T; Yang L; Ma GM; Li CX; Bai Y; Zhao JA; Wang XL; Geng CZ
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2261-4. PubMed ID: 20095338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-negative breast cancer survival in Iranian patients.
    Aghili M; Lashkari M; Farrokhpey AH; Izadi S
    Acta Med Iran; 2013 Sep; 51(8):560-6. PubMed ID: 24026994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
    Ulaner GA; Castillo R; Goldman DA; Wills J; Riedl CC; Pinker-Domenig K; Jochelson MS; Gönen M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1937-44. PubMed ID: 27129866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple negative breast cancer in people of North East India: critical insights gained at a regional cancer centre.
    Sharma M; Sharma JD; Sarma A; Ahmed S; Kataki AC; Saxena R; Sharma D
    Asian Pac J Cancer Prev; 2014; 15(11):4507-11. PubMed ID: 24969877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Risk of Recurrence by Subtype in ≤ 1-cm Breast Tumors.
    Colonna SV; Higgins AK; Alvarez J; Saville BR; Lawrence J; Abramson VG
    Clin Breast Cancer; 2016 Jun; 16(3):223-31. PubMed ID: 26683741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implication of leucine zipper/EF hand-containing transmembrane-1 overexpression in the prognosis of triple-negative breast cancer.
    Wang CA; Liu Q; Chen Y; Liu S; Xu J; Cui X; Zhang Y; Piao L
    Exp Mol Pathol; 2015 Apr; 98(2):254-9. PubMed ID: 25617527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
    Chen HL; Ding A
    Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients.
    Gaceb H; Cherbal F; Bakour R; Ould-Rouis A; Mahfouf H
    Pathol Oncol Res; 2018 Apr; 24(2):297-308. PubMed ID: 28478614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related frequency of triple negative breast cancer in women.
    Sajid MT; Ahmed M; Azhar M; Mustafa QU; Shukr I; Ahmed M; Kamal Z
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):400-3. PubMed ID: 24953912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TTK is a favorable prognostic biomarker for triple-negative breast cancer survival.
    Xu Q; Xu Y; Pan B; Wu L; Ren X; Zhou Y; Mao F; Lin Y; Guan J; Shen S; Zhang X; Wang C; Zhong Y; Zhou L; Liang Z; Zhao H; Sun Q
    Oncotarget; 2016 Dec; 7(49):81815-81829. PubMed ID: 27833085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.
    de Nonneville A; Gonçalves A; Zemmour C; Cohen M; Classe JM; Reyal F; Colombo PE; Jouve E; Giard S; Barranger E; Sabatier R; Bertucci F; Boher JM; Houvenaeghel G
    Eur J Cancer; 2017 Oct; 84():34-43. PubMed ID: 28780480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
    Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U
    BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of pN0 Triple-Negative Breast Cancer with or without Lymph Node Irradiation: A Single Institution Experience.
    Khalifa J; Duprez-Paumier R; Filleron T; Lacroix Triki M; Jouve E; Dalenc F; Massabeau C
    Breast J; 2016 Sep; 22(5):510-9. PubMed ID: 27261365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.